NCT04122040

Effects of Roxithromycin on Quality of Life and Physiological Outcomes in Bronchiectasis

Effects of Roxithromycin on Quality of Life and Physiologic Outcomes in Bronchiectasis Patients During Treatment and Posttreatment Period

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Prince of Songkla University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

roxithormycin 300 mg per day for 12 weeks could improve quality of life and physiological outcomes in bronchiectasis

Detailed description

A randomized, double blinded, placebo controlled study was conducted to evaluate the effects of a 12-week administration of roxithromycin 300 mg once daily and a 12-week follow-up period in symptomatic stable bronchiectasis

Conditions

• Quality of Life
• Respiratory Function Tests

Interventions

Type	Name	Description
DRUG	Roxithromycin 300 MG	Roxithromycin 300 mg oral per day
DRUG	Placebo	Placebo one table oral once dialy

Timeline

• Start date: 2011-03-01
• Primary completion: 2011-09-30
• Completion: 2011-09-30
• First posted: 2019-10-10
• Last updated: 2019-10-14